Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Review(RS)-(Tetrazol-5-yl)glycine
Description: Highly potent NMDA agonist
Purity: ≥98% (HPLC)
Biological Activity for (RS)-(Tetrazol-5-yl)glycine
(RS)-(Tetrazol-5-yl)glycine is a potent NMDA receptor agonist, approximately 20 times more active than NMDA.
Technical Data for (RS)-(Tetrazol-5-yl)glycine
| M. Wt | 143.1 |
| Formula | C3H5N5O2 |
| Storage | Store at RT |
| Purity | ≥98% (HPLC) |
| CAS Number | 138199-51-6 |
| PubChem ID | 126383 |
| InChI Key | UKBRUIZWQZHXFL-UHFFFAOYSA-N |
| Smiles | NC(C(O)=O)C1=NN=NN1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for (RS)-(Tetrazol-5-yl)glycine
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 50 |
Preparing Stock Solutions for (RS)-(Tetrazol-5-yl)glycine
The following data is based on the product molecular weight 143.1. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 13.98 mL | 69.88 mL | 139.76 mL |
| 2.5 mM | 2.8 mL | 13.98 mL | 27.95 mL |
| 5 mM | 1.4 mL | 6.99 mL | 13.98 mL |
| 25 mM | 0.28 mL | 1.4 mL | 2.8 mL |
Molarity Calculator
Molarity Calculator
Calculate the mass, volume, or concentration required for a solution.
Reconstitution Calculator
Reconstitution Calculator
Dilution Calculator
Dilution Calculator
Calculate the dilution required to prepare a stock solution.
Product Datasheets for (RS)-(Tetrazol-5-yl)glycine
References for (RS)-(Tetrazol-5-yl)glycine
References are publications that support the biological activity of the product.
Arnt et al (1995) Diffentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity. Eur.J.Pharmacol. 285 289 PMID: 8575516
Moroni et al (1995) NMDA receptor heterogeneity in mammalian tissues: focus on two agonists, (2S,3R,4S)cyclopropylglutamate and the sulfate ester of 4-hydroxy-(S)-pipecolic acid. Naunyn Schmiedebergs Arch.Pharmacol. 351 371 PMID: 7543185
Schoepp et al (1991) D,L-(Tetrazol-5-yl)glycine a novel and highly potent NMDA receptor agonist. Eur.J.Pharmacol. 203 237 PMID: 1686860
If you know of a relevant reference for (RS)-(Tetrazol-5-yl)glycine, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: (RS)-(Tetrazol-5-yl)glycine, (RS)-(Tetrazol-5-yl)glycine supplier, potent, NMDA, receptor, agonists, Glutamate, Receptors, N-Methyl-D-Aspartate, iGluR, Ionotropic, 0312, Tocris Bioscience
Citations for (RS)-(Tetrazol-5-yl)glycine
Citations are publications that use Tocris products.
Currently there are no citations for (RS)-(Tetrazol-5-yl)glycine. Do you know of a great paper that uses (RS)-(Tetrazol-5-yl)glycine from Tocris? Please let us know.
Reviews for (RS)-(Tetrazol-5-yl)glycine
There are currently no reviews for this product. Be the first to review (RS)-(Tetrazol-5-yl)glycine and earn rewards!
Have you used (RS)-(Tetrazol-5-yl)glycine?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Huntington's Disease Research Product Guide
This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:
- Somatic Instability
- Proteolysis and Inclusion Bodies
- Transcriptional Dysregulation
- Mitochondrial Dysfunction
- Nuclear-Cytoplasmic Transport Interference
- Excitotoxicity
- Stem Cells
Alzheimer's Disease Poster
Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
Huntington's Disease Poster
Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.
Parkinson's Disease Poster
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.